help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 20, 2007
Endocrinology, doi:10.1210/en.2007-0980
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/4/1470    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Iglesias, A. E.
Right arrow Articles by Stojilkovic, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Iglesias, A. E.
Right arrow Articles by Stojilkovic, S. S.

Submitted on July 18, 2007
Accepted on December 10, 2007

Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways

Arturo E. Gonzalez-Iglesias, Takayo Murano, Shuo Li, Melanija Tomic, and Stanko S. Stojilkovic*

Section on Cellular Signaling, Program in Developmental Neuroscience, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-4510

* To whom correspondence should be addressed. E-mail: stankos{at}helix.nih.gov.

Dopamine D2 receptors signal through the pertussis toxin (PTX)-sensitive Gi/o and PTX-insensitive Gz proteins, as well as through a G protein-independent, {beta}-arrestin/GSK3-depen-dent pathway. Activation of these receptors in pituitary lactotrophs leads to inhibition of prolactin (PRL) release. It has been suggested that this inhibition occurs through the Gi/o-{alpha} protein-mediated inhibition of cAMP production and/or Gi/o-{beta}{gamma} dimer-mediated activation of inward rectifier K+ channels and inhibition of voltage-gated Ca2+ channels. Here we show that the dopamine agonist-induced inhibition of spontaneous Ca2+ influx and release of pre-stored PRL was preserved when cAMP levels were elevated by forskolin treatment. We further observed that dopamine agonists inhibited both spontaneous and depolarization-induced Ca2+ influx in untreated but not in PTX-treated cells. This inhibition was also observed in cells with blocked inward rectifier K+ channels, suggesting that dopamine effect on voltage-gated Ca2+ channel gating is sufficient to inhibit spontaneous Ca2+ influx. However, agonist-induced inhibition of PRL release was only partially relieved in PTX-treated cells, indicating that dopamine receptors also inhibit exocytosis downstream of voltage-gated Ca2+ influx. The PTX-insensitive step in agonist-induced inhibition of PRL release was not affected by the addition of wortmannin, an inhibitor of PI3-kinase, and lithium, an inhibitor of GSK-3, but was attenuated in the presence of phorbol ester PMA, which inhibits Gz signaling pathway in a protein kinase C-dependent manner. Thus, dopamine inhibits basal PRL release by blocking voltage-gated Ca2+ influx through the PTX-sensitive-signaling pathway and by desensitizing Ca2+-secretion coupling through the PTX-insensitive and protein kinase C-sensitive signaling pathway.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society